EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Quantitative calibration of a spatial QSP model identifies fibroblast impact on HCC immunotherapy

Shuming Zhang iD, Hanwen Wang iD, Yeonju Cho iD, Heber L Rocha iD, Wendy Wong, Mark Yarchoan iD, Elizabeth M Jaffee, Won Jin Ho, Luciane T Kagohara, Elana J Fertig iD, Aleksander S Popel iD, Atul Deshpande iD

Proceedings of the National Academy of Sciences · 21.07.2026 · 123 (29)

DOI: 10.1073/pnas.2525799123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 14.07.2026. Verfasst von Shuming Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205. Hauptthemen laut MEDLINE: Liver Neoplasms, Immunotherapy, Fibroblasts, Carcinoma, Hepatocellular. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Foundation for the NIH (FNIH), DOD | USA | U.S. Army Medical Command (MEDCOM).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Computational models are increasingly used to predict treatment response and optimize cancer therapeutic strategies. Quantitative systems pharmacology (QSP) models mechanistically simulate tumor progression and pharmacological interventions, enabling virtual clinical trials, model-informed drug development, and biomarker discovery, but they lack spatial resolution to represent tumor microenvironment (TME) architecture. Coupling QSP with agent-based modeling creates spatial QSP (spQSP) frameworks capable of resolving tissue-level organization at single-cell resolution; however, parameterizing these models with human tumor data remains challenging. Here, we extend an existing spQSP model of liver cancer by mechanistically incorporating a fibroblast module and develop an Approximate Bayesian Computation–Sequential Monte Carlo calibration pipeline that integrates spatial molecular data. This calibration framework matches tumor architectures between spQSP simulations and spatial molecular data by fitting statistical summaries of cellular neighborhoods. The calibrated model reproduces fibroblast-mediated exclusion of lymphocyte infiltration observed in spatial transcriptomics and predicts posttreatment spatial tumor states in an independent cohort receiving immune checkpoint inhibitor and tyrosine kinase inhibitor combination therapy. Finally, we identify spatial and nonspatial pretreatment biomarkers associated with therapeutic response. Together, this study demonstrates how integrating spatial omics with mechanistic modeling enables quantitative calibration, reveals the spatial role of fibroblasts in shaping immunosuppressive TMEs, and supports in silico biomarker discovery toward personalized cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsImmunotherapyFibroblastsCarcinoma, HepatocellularHumansTumor MicroenvironmentBayes TheoremCalibrationModels, BiologicalMonte Carlo MethodComputer Simulation

Stichwörter der Autor:innen

bioinformaticscomputational medicinecomputational oncologymathematical biologysystem biology

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Convergence Institute, Johns Hopkins University, Baltimore, MD 21205.
  • Department of Intelligent Systems Engineering, Indiana University, Bloomington, IN 47405.
  • Bloomberg-Kimmel Immunotherapy Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD 21201.

ORCID-Profile: Shuming Zhang, Hanwen Wang, Yeonju Cho, Heber L Rocha, Mark Yarchoan, Elana J Fertig, Aleksander S Popel, Atul Deshpande

Förderung

  • NCI NIH HHS
  • Foundation for the NIH (FNIH)
  • DOD | USA | U.S. Army Medical Command (MEDCOM)

Zitieren

APA

Zhang, S., Wang, H., Cho, Y., Rocha, H. L., Wong, W., Yarchoan, M., Jaffee, E. M., Ho, W. J., Kagohara, L. T., Fertig, E. J., Popel, A. S., & Deshpande, A. (2026). Quantitative calibration of a spatial QSP model identifies fibroblast impact on HCC immunotherapy. Proceedings of the National Academy of Sciences, 123(29). https://doi.org/10.1073/pnas.2525799123

Vancouver

Zhang S, Wang H, Cho Y, Rocha HL, Wong W, Yarchoan M, et al. Quantitative calibration of a spatial QSP model identifies fibroblast impact on HCC immunotherapy. Proceedings of the National Academy of Sciences. 2026;123(29). doi:10.1073/pnas.2525799123

BibTeX
@article{Zhang2026,
  author = {Zhang, Shuming and Wang, Hanwen and Cho, Yeonju and Rocha, Heber L and Wong, Wendy and Yarchoan, Mark and Jaffee, Elizabeth M and Ho, Won Jin and Kagohara, Luciane T and Fertig, Elana J and Popel, Aleksander S and Deshpande, Atul},
  title = {Quantitative calibration of a spatial QSP model identifies fibroblast impact on HCC immunotherapy},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {29},
  doi = {10.1073/pnas.2525799123}
}
Kostenlos starten →